Aurobindo: FDA approves Didanosine chewable tablets for AIDS prevention

By Lisa Kerner

Charlotte, N.C., July 12 - Aurobindo Pharma Ltd. said the Food and Drug Administration has granted tentative approval for Didanosine Tablets (chewable) (100 mg, 150 mg and 200 mg), the generic version of Bristol-Myers Squibb's Videx.

Didanosine helps prevent the AIDS virus from reproducing and is used in combination with other antiviral agents for the treatment of HIV-1 infection.

Aurobindo is a pharmaceutical company located in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.